TAS-102 Demonstrates Prolonged Survival in Patients With Previously Treated Metastatic Gastric Cancer
Publish date unknown
In findings from the phase III TAGS study reported at the 2018 World Gastrointestinal Cancer Congress, TAS-102 (trifluridine/tipiracil; ...